Risk-adapted therapy in adults with Burkitt lymphoma: Updated results of a multicenter prospective Phase II study of DA-EPOCH-R Meeting Abstract
| Authors: | Dunleavy, K.; Roschewski, M.; Abramson, J. S.; Link, B.; Parekh, S.; Jagadeesh, D.; Bierman, P.; Watson, P. R.; Peace, D.; Hanna, W.; Powell, B.; Melani, C.; Lucas, A.; Steinberg, S. M.; Kahl, B.; Friedberg, J. W.; Little, R. F.; Bartlett, N. L.; Fanale, M. A.; Noy, A.; Wilson, W. H. |
| Abstract Title: | Risk-adapted therapy in adults with Burkitt lymphoma: Updated results of a multicenter prospective Phase II study of DA-EPOCH-R |
| Meeting Title: | 14th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Jun 14-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-06-07 |
| Start Page: | 133 |
| End Page: | 134 |
| Language: | English |
| ACCESSION: | 123459853 |
| DOI: | 10.1002/hon.2437_122 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 123 -- Accession Number: 123459853 -- Entry Date: In Process -- Revision Date: 20170608 -- Publication Type: Article -- Supplement Title: Jun2017 Supplement -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
